mRNA-1273.214

N/A

Report date: 2026/05/13 09:17:30

Base Information

Drug NamemRNA-1273.214
Drug Alias NameOmicron-specific bivalent booster candidatemRNA-1273.214
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2022/08/16
Country/TerritoryPanamaUnited StatesPuerto Rico +[10] 
CombinationsYes mRNA-1273.529Elasomeran
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncMurdoch Childrens Research Institute
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A